U.S.
Central Venous Catheter Market, by Product Type (Peripherally Inserted
Central Catheters (PICC), Implantable Ports, Tunneled Central Venous Catheter,
and Non-tunneled Central Venous Catheter), by Design (Single Lumen, Double
Lumen, and Multi Lumen), by Composition (Polyurethane, Polyethylene, and
Silicon), by Procedure (Cardiovascular Procedure, Chemotherapy Procedure, and
Dialysis Procedure), and by End User (Hospitals, Ambulatory Surgical Centers,
and Specialty Clinics) was valued at US$ 825.9 million in 2018, and is
projected to exhibit a CAGR of 6.2% over the forecast period (2018 – 2026).
Increasing prevalence of renal
diseases and cancer is expected to augment the market growth Increasing
prevalence of diseases that require long-term therapies such as cancer
(chemotherapy) and end stage renal disease (dialysis) is expected to fuel
growth of the U.S. central venous catheter market. According to the National
Center for Chronic Disease Prevention and Health Promotion, 2017, around 30
million people or 15% of the U.S. adults were estimated to have chronic kidney.
According to the World Health Organization (WHO), 2012, cancer is the second
leading cause of morbidity and mortality worldwide, with around 14 million new
cases registered in 2012. Furthermore, WHO stated that the number of new cases
is expected to rise by around 70% by 2030. Also, in 2015, cancer was
responsible for 8.8 million deaths globally.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/2610
Browse 38 Market Data Tables and
34 Figures spread through 117 Pages and in-depth TOC on ‘U.S. Central Venous
Catheter Market - U.S. Forecast to 2026, by Product Type (Peripherally Inserted
Central Catheters (PICC), Implantable Ports, Tunneled Central Venous Catheter,
and Non-tunneled Central Venous Catheter), by Design (Single Lumen, Double
Lumen, and Multi Lumen), by Composition (Polyurethane, Polyethylene, and
Silicon), by Procedure (Cardiovascular Procedure, Chemotherapy Procedure, and
Dialysis Procedure), and by End User (Hospitals, Ambulatory Surgical Centers,
and Specialty Clinics)
Key players in the market are
focused on adopting strategies such as mergers and acquisitions to enhance
their product portfolio. For instance in July 2018, B. Braun Melsungen AG
acquired bloodlines business of NxStage Medical, Inc. Similarly, in 2017,
Becton, Dickinson, and Company acquired C.R. Bard, Inc. which created a new
health care industry leader with approximately US$16 billion in annualized
revenue
Key Takeaways of the Central
Venous Catheter Market:
The U.S. central venous catheter
market is expected to exhibit a CAGR of 6.2% over the forecast period, owing to
increasing prevalence of cancer
Among product type, the
peripherally inserted central catheters (PICC) segment held a dominant position
in the Central Venous Catheter Market in 2018, owing to high commercially
availability of peripherally inserted central catheters
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/us-central-venous-catheter-market-2610
Among designs, the multi lumen
segment held a dominant position in the Central Venous Catheter Market in 2018,
owing to high adaption of multi lumen catheters
Among compositions, the
polyurethane segment held a dominant position in the Central Venous Catheter
Market in 2018, due to properties of polyurethane such as toughness, thinner
lumen walls, and larger internal diameter
Among procedures, the
chemotherapy procedure segment held a dominant position in the Central Venous
Catheter Market in 2018, owing to high prevalence of cancer
Key players operating in the S.
central venous catheter market include, Cobra Biologics and Pharmaceutical
Services, VGXI, Inc., Aldevron, Kaneka Corporation, Nature Technology
Corporation, PlasmidFactory GmbH & Co. KG, Cell and Gene Therapy Catapult,
Waisman Biomanufacturing, AngioDynamics, Inc., C. R. Bard, Inc., Teleflex
Incorporated, B. Braun Melsungen AG, Medtronic Plc., Vygon Ltd., Cook Medical,
Inc., Argon Medical Devices, Inc., ICU Medical, Inc., and Theragenics
Corporation
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/2610
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting services,
and competitive analysis through various recommendations related to emerging
market trends, technologies, and potential absolute dollar opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN
: +050-5539-1737
No comments:
Post a Comment